Neutrophils: Markers of biological age and predictors of longevity

Neutrophils: Lifespan, Functions and Roles in Disease

Volumn , Issue , 2010, Pages 77-120

  Alonso Fernández, Patricia ^a   Maté, Ianire ^b   De La Fuente, Mónica ^b  

^a HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895207371     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (238)

1. Borkan GA, Norris AH. Assessment of biological age using a profile of physical parameters. J Gerontol. Mar 1980;35(2):177-184.
2. Borkan GA, Norris AH. Biological age in adulthood: comparison of active and inactive U.S. males. Hum Biol. Dec 1980;52(4):787-802.
3. Makinodan T, Kay MM. Age influence on the immune system. Adv Immunol 1980;29:287-330.
4. Murasko DM, Nelson BJ, Silver R, Matour D, Kaye D. Immunologic response in an elderly population with a mean age of 85. Am J Med. Oct 1986;81(4):612-618.
5. Bender BS. Infectious disease risk in the elderly. Immunol Allergy Clin North Am. Feb 2003;23(1):57-64, vi.
6. Falsey AR, Walsh EE. Respiratory syncytial virus infection in elderly adults. Drugs Aging. 2005;22(7):577-587.
7. High KP, Bradley S, Loeb M, Palmer R, Quagliarello V, Yoshikawa T. A new paradigm for clinical investigation of infectious syndromes in older adults: assessment of functional status as a risk factor and outcome measure. Clin Infect Dis. Jan 1 2005;40(1):114-122.
8. Nichol KL. Influenza vaccination in the elderly: impact on hospitalisation and mortality. Drugs Aging. 2005;22(6):495-515.
9. O'Meara ES, White M, Siscovick DS, Lyles MF, Kuller LH. Hospitalization for pneumonia in the Cardiovascular Health Study: incidence, mortality, and influence on longer-term survival. J Am Geriatr Soc. Jul 2005;53(7):1108-1116.
10. Franceschi C, Monti D, Barbieri D, et al. Immunosenescence in humans: deterioration or remodelling? Int Rev Immunol. 1995;12(1):57-74.
11. Miller RA. The aging immune system: primer and prospectus. Science. Jul 5 1996;273(5271):70-74.
12. Pawelec G, Effros RB, Caruso C, Remarque E, Barnett Y, Solana R. T cells and aging (update february 1999). Front Biosci. Mar 1 1999;4:D216-269.
13. Effros RB. Ageing and the immune system. Novartis Found Symp. 2001;235:130-139; discussion 139-145, 146-139.
14. Kohut ML, Senchina DS. Reversing age-associated immunosenescence via exercise. Exerc Immunol Rev 2004;10:6-41.
15. Strehler BL. Time, cells and aging. New York: Academic Press-1977.
16. Kirkwood TB, Feder M, Finch CE, et al. What accounts for the wide variation in life span of genetically identical organisms reared in a constant environment? Mech Ageing Dev. Mar 2005;126(3):439-443.
17. Sander M, Avlund K, Lauritzen M, et al. Aging-from molecules to populations. Mech Ageing Dev. Oct 2008;129(10):614-623.
18. Finkel D, Whitfield K, McGue M. Genetic and environmental influences on functional age: a twin study. J Gerontol B Psychol Sci Soc Sci. Mar 1995;50(2):P104-113.
19. Bae CY, Kang YG, Kim S, et al. Development of models for predicting biological age (BA) with physical, biochemical, and hormonal parameters. Arch Gerontol Geriatr. Sep-Oct 2008;47(2):253-265.
20. Wayne SJ, Rhyne RL, Garry PJ, Goodwin JS. Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60. J Gerontol. Mar 1990;45(2):M45-48.
21. Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A Biol Sci Med Sci. Nov 1995;50(6):B378-382.
22. Ma YX, Yue Z, Wang ZS, et al. Physiological basis for long life span. Mech Ageing Dev. Oct 1997;98(1):47-55.
23. Ogata K, Yokose N, Tamura H, et al. Natural killer cells in the late decades of human life. Clin Immunol Immunopathol. Sep 1997;84(3):269-275.
24. Guayerbas N, Puerto M, Victor VM, Miquel J, De la Fuente M. Leukocyte function and life span in a murine model of premature immunosenescence. Exp Gerontol. Jan-Mar 2002;37(2-3):249-256.
25. Guayerbas N, Catalan M, Victor VM, Miquel J, De la Fuente M. Relation of behaviour and macrophage function to life span in a murine model of premature immunosenescence. Behav Brain Res. Aug 21 2002;134(1-2):41-48.
26. Guayerbas N, De La Fuente M. An impairment of phagocytic function is linked to a shorter life span in two strains of prematurely aging mice. Dev Comp Immunol. Apr 2003;27(4):339-350.
27. Medvedev ZA. An attempt at a rational classification of theories of ageing. Biol Rev Camb Philos Soc. Aug 1990;65(3):375-398.
28. Carnes BA, Staats DO, Sonntag WE. Does senescence give rise to disease? Mech Ageing Dev. Dec 2008;129(12):693-699.
29. Vina J, Borras C, Miquel J. Theories of ageing. IUBMB Life. Apr-May 2007;59(4-5):249-254.
30. Hayflick L. The Limited in Vitro Lifetime of Human Diploid Cell Strains. Exp Cell Res. Mar 1965;37:614-636.
31. Goyns MH. Genes, telomeres and mammalian ageing. Mech Ageing Dev. Apr 2002;123(7):791-799.
32. Pearl R. The rate of living. London: University of London Press. 1928.
33. Weissman A. Essays upon heredity and kindred biological problems. London-New York: Oxford University Press-Clarendon. 1891.
34. Hayflick L. Biological aging is no longer an unsolved problem. Ann N Y Acad Sci. Apr 2007;1100:1-13.
35. Miquel J, Economos AC, Fleming J, Johnson JE, Jr. Mitochondrial role in cell aging. Exp Gerontol. 1980;15(6):575-591.
36. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. Jul 1956;11(3):298-300.
37. Harman D. The biologic clock: the mitochondria? J Am Geriatr Soc. Apr 1972;20(4):145-147.
38. Miquel J. An integrated theory of aging as the result of mitochondrial-DNA mutation in differentiated cells. Arch Gerontol Geriatr. Mar-Jun 1991;12(2-3):99-117.
39. Williams GC. Pleiotropy, natural selection and the evolution of senescence. Evolution 1957;2:397-411.
40. De la Fuente M, Miquel J. An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging. Curr Pharm Des. 2009;15(26):3003-3026.
41. De la Fuente M, Hernanz A, Vallejo MC. The immune system in the oxidative stress conditions of aging and hypertension: favorable effects of antioxidants and physical exercise. Antioxid Redox Signal. Sep-Oct 2005;7(9-10):1356-1366.
42. De la Fuente M. Role of neuroimmunomodulation in aging. Neuroimmunomodulation. 2008;15(4-6):213-223.
43. De la Fuente M. The immune system as a marker of health and longevity. . Antiaging Med. 2004;1:31-41.
44. Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev. Feb 1996;17(1):64-102.
45. Wrona D. Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. J Neuroimmunol. Mar 2006;172(1-2):38-58.
46. Besedovsky HO, Rey AD. Physiology of psychoneuroimmunology: a personal view. Brain Behav Immun. Jan 2007;21(1):34-44.
47. Blalock JE. The immune system as a sensory organ. J Immunol. Mar 1984;132(3):1067-1070.
48. Arranz L, Guayerbas N, De la Fuente M. Impairment of several immune functions in anxious women. J Psychosom Res. Jan 2007;62(1):1-8.
49. Arranz L, de Vicente A, Munoz M, De la Fuente M. Impaired immune function in a homeless population with stress-related disorders. Neuroimmunomodulation. 2009;16(4):251-260.
50. Barak Y. The immune system and happiness. Autoimmun Rev. Oct 2006;5(8):523-527.
51. Merril JE. Production and influence of inflammatory cytokines in diseases of the adult central nervous system. San Diego: Academic Press; 2001.
52. Smith RG, Betancourt L, Sun Y. Molecular endocrinology and physiology of the aging central nervous system. Endocr Rev. Apr 2005;26(2):203-250.
53. Fabris N. A neuroendocrine-immune theory of aging. Int J Neurosci. Apr 1990;51(3-4):373-375.
54. High KP. Infection as a cause of age-related morbidity and mortality. Ageing Res Rev. Jan 2004;3(1):1-14.
55. Ortega E, Garcia JJ, De La Fuente M. Ageing modulates some aspects of the nonspecific immune response of murine macrophages and lymphocytes. Exp Physiol. Sep 2000;85(5):519-525.
56. Sebastian C, Espia M, Serra M, Celada A, Lloberas J. MacrophAging: a cellular and molecular review. Immunobiology. 2005;210(2-4):121-126.
57. Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol. Jan 2007;211(2):144-156.
58. Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology. Apr 2007;120(4):435-446.
59. Kumar R, Burns EA. Age-related decline in immunity: implications for vaccine responsiveness. Expert Rev Vaccines. May 2008;7(4):467-479.
60. Pawelec G, Barnett Y, Forsey R, et al. T cells and aging, January 2002 update. Front Biosci. May 1 2002;7:d1056-1183.
61. Gregg R, Smith CM, Clark FJ, et al. The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age. Clin Exp Immunol. Jun 2005;140(3):540-546.
62. Trzonkowski P, Szmit E, Mysliwska J, Mysliwski A. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin Immunol. Jun 2006;119(3):307-316.
63. Solana R, Pawelec G, Tarazona R. Aging and innate immunity. Immunity. May 2006;24(5):491-494.
64. Ginaldi L, De Martinis M, D'Ostilio A, Marini L, Loreto MF, Quaglino D. The immune system in the elderly: III. Innate immunity. Immunol Res. 1999;20(2):117-126.
65. de la Fuente M, Hernanz A, Guayerbas N, Alvarez P, Alvarado C. Changes with age in peritoneal macrophage functions. Implication of leukocytes in the oxidative stress of senescence. Cell Mol Biol (Noisy-le-grand). 2004;50 Online Pub:OL683-690.
66. De la Fuente M, Hernanz A, Guayerbas N, Victor VM, Arnalich F. Vitamin E ingestion improves several immune functions in elderly men and women. Free Radic Res. Mar 2008;42(3):272-280.
67. Gomez CR, Nomellini V, Faunce DE, Kovacs EJ. Innate immunity and aging. Exp Gerontol. Aug 2008;43(8):718-728.
68. Lord JM, Butcher S, Killampali V, Lascelles D, Salmon M. Neutrophil ageing and immunesenescence. Mech Ageing Dev. Sep 30 2001;122(14):1521-1535.
69. Rafi A, Castle SC, Uyemura K, Makinodan T. Immune dysfunction in the elderly and its reversal by antihistamines. Biomed Pharmacother. Jul-Aug 2003;57(5-6):246-250.
70. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. Feb 2004;5(2):133-139.
71. Castle SC, Uyemura K, Fulop T, Makinodan T. Host resistance and immune responses in advanced age. Clin Geriatr Med. Aug 2007;23(3):463-479, v.
72. De La Fuente M. Changes in the macrophage function with aging. Comp Biochem Physiol A Comp Physiol. 1985;81(4):935-938.
73. Ogata K, An E, Shioi Y, et al. Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol. Jun 2001;124(3):392-397.
74. Niwa Y, Kasama T, Miyachi Y, Kanoh T. Neutrophil chemotaxis, phagocytosis and parameters of reactive oxygen species in human aging: cross-sectional and longitudinal studies. Life Sci. 1989;44(22):1655-1664.
75. van Duin D, Allore HG, Mohanty S, et al. Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults. J Infect Dis. Jun 1 2007;195(11):1590-1597.
76. Kong KF, Delroux K, Wang X, et al. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J Virol. Aug 2008;82(15):7613-7623.
77. Solana R, Alonso MC, Pena J. Natural killer cells in healthy aging. Exp Gerontol. Jun 1999;34(3):435-443.
78. Mocchegiani E, Malavolta M. NK and NKT cell functions in immunosenescence. Aging Cell. Aug 2004;3(4):177-184.
79. Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ. Aging and innate immune cells. J Leukoc Biol. Aug 2004;76(2):291-299.
80. Shodell M, Siegal FP. Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing. Scand J Immunol. Nov 2002;56(5):518-521.
81. De la Fuente M. Effects of antioxidants on immune system ageing. Eur J Clin Nutr. Aug 2002;56 Suppl 3:S5-8.
82. Villanueva JL, Solana R, Alonso MC, Pena J. Changes in the expression of HLA-class II antigens on peripheral blood monocytes from aged humans. Dis Markers. Mar-Apr 1990;8(2):85-91.
83. Njemini R, Lambert M, Demanet C, Mets T. Heat shock protein 32 in human peripheral blood mononuclear cells: effect of aging and inflammation. J Clin Immunol. Sep 2005;25(5):405-417.
84. Mollinedo F, Borregaard N, Boxer LA. Novel trends in neutrophil structure, function and development. Immunol Today. Dec 1999;20(12):535-537.
85. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. May 15 2003;101(10):3765-3777.
86. van den Berg JM, Weyer S, Weening JJ, Roos D, Kuijpers TW. Divergent effects of tumor necrosis factor alpha on apoptosis of human neutrophils. J Leukoc Biol. Mar 2001;69(3):467-473.
87. Fortin CF, McDonald PP, Lesur O, Fulop T, Jr. Aging and neutrophils: there is still much to do. Rejuvenation Res. Oct 2008;11(5):873-882.
88. Schroder AK, Rink L. Neutrophil immunity of the elderly. Mech Ageing Dev. Apr 2003;124(4):419-425.
89. Fortin CF, Lesur O, Fulop T, Jr. Effects of aging on triggering receptor expressed on myeloid cells (TREM)-1-induced PMN functions. FEBS Lett. Mar 20 2007;581(6):1173-1178.
90. Segal AW, Abo A. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem Sci. Feb 1993;18(2):43-47.
91. Meydani SN, Wu D, Santos MS, Hayek MG. Antioxidants and immune response in aged persons: overview of present evidence. Am J Clin Nutr. Dec 1995;62(6 Suppl):1462S-1476S.
92. Carmody RJ, Cotter TG. Signalling apoptosis: a radical approach. Redox Rep. 2001;6(2):77-90.
93. Kinnula VL, Soini Y, Kvist-Makela K, Savolainen ER, Koistinen P. Antioxidant defense mechanisms in human neutrophils. Antioxid Redox Signal. Feb 2002;4(1):27-34.
94. Roos D, Weening RS, Voetman AA. Protection of human neutrophils against oxidative damage. Agents Actions. Dec 1980;10(6):528-535.
95. Narayanan PK, Ragheb K, Lawler G, Robinson JP. Defects in intracellular oxidative metabolism of neutrophils undergoing apoptosis. J Leukoc Biol. Apr 1997;61(4):481-488.
96. O'Neill AJ, O'Neill S, Hegarty NJ, et al. Glutathione depletion-induced neutrophil apoptosis is caspase 3 dependent. Shock. Dec 2000;14(6):605-609.
97. Ogino T, Packer L, Maguire JJ. Neutrophil antioxidant capacity during the respiratory burst: loss of glutathione induced by chloramines. Free Radic Biol Med. 1997;23(3):445-452.
98. van den Dobbelsteen DJ, Nobel CS, Schlegel J, Cotgreave IA, Orrenius S, Slater AF. Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody. J Biol Chem. Jun 28 1996;271(26):15420-15427.
99. Watson RW, Rotstein OD, Jimenez M, Parodo J, Marshall JC. Augmented intracellular glutathione inhibits Fas-triggered apoptosis of activated human neutrophils. Blood. Jun 1 1997;89(11):4175-4181.
100. Scheel-Toellner D, Wang K, Craddock R, et al. Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood. Oct 15 2004;104(8):2557-2564.
101. Alonso-Fernandez P, Puerto M, Mate I, Ribera JM, de la Fuente M. Neutrophils of centenarians show function levels similar to those of young adults. J Am Geriatr Soc. Dec 2008;56(12):2244-2251.
102. Ligthart GJ, Corberand JX, Fournier C, et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev. Nov 1984;28(1):47-55.
103. Ferrandez MD, De la Fuente M. Effects of age, sex and physical exercise on the phagocytic process of murine peritoneal macrophages. Acta Physiol Scand. May 1999;166(1):47-53.
104. Esparza B, Sanchez H, Ruiz M, Barranquero M, Sabino E, Merino F. Neutrophil function in elderly persons assessed by flow cytometry. Immunol Invest. May 1996;25(3):185-190.
105. Alvarez E, Ruiz-Gutierrez V, Sobrino F, Santa-Maria C. Age-related changes in membrane lipid composition, fluidity and respiratory burst in rat peritoneal neutrophils. Clin Exp Immunol. Apr 2001;124(1):95-102.
106. Zou Y, Jung KJ, Kim JW, Yu BP, Chung HY. Alteration of soluble adhesion molecules during aging and their modulation by calorie restriction. FASEB J. Feb 2004;18(2):320-322.
107. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. Oct 2000;1(1):31-39.
108. Fortin CF, Larbi A, Lesur O, Douziech N, Fulop T, Jr. Impairment of SHP-1 downregulation in the lipid rafts of human neutrophils under GM-CSF stimulation contributes to their age-related, altered functions. J Leukoc Biol. May 2006;79(5):1061-1072.
109. Fulop T, Larbi A, Douziech N, et al. Signal transduction and functional changes in neutrophils with aging. Aging Cell. Aug 2004;3(4):217-226.
110. Tortorella C, Simone O, Piazzolla G, Stella I, Antonaci S. Age-related impairment of GM-CSF-induced signalling in neutrophils: role of SHP-1 and SOCS proteins. Ageing Res Rev. Aug 2007;6(2):81-93.
111. Tortorella C, Simone O, Piazzolla G, Stella I, Cappiello V, Antonaci S. Role of phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways in granulocyte macrophage-colony-stimulating factor failure to delay fas-induced neutrophil apoptosis in elderly humans. J Gerontol A Biol Sci Med Sci. Nov 2006;61(11):1111-1118.
112. Larbi A, Fulop T, Pawelec G. Immune receptor signaling, aging and autoimmunity. Adv Exp Med Biol 2008;640:312-324.
113. Polignano A, Tortorella C, Venezia A, Jirillo E, Antonaci S. Age-associated changes of neutrophil responsiveness in a human healthy elderly population. Cytobios. 1994;80(322):145-153.
114. Wenisch C, Patruta S, Daxbock F, Krause R, Horl W. Effect of age on human neutrophil function. J Leukoc Biol. Jan 2000;67(1):40-45.
115. Egger G, Aigner R, Glasner A, Hofer HP, Mitterhammer H, Zelzer S. Blood polymorphonuclear leukocyte migration as a predictive marker for infections in severe trauma: comparison with various inflammation parameters. Intensive Care Med. Feb 2004;30(2):331-334.
116. Egger G, Burda A, Mitterhammer H, Baumann G, Bratschitsch G, Glasner A. Impaired blood polymorphonuclear leukocyte migration and infection risk in severe trauma. J Infect. Aug 2003;47(2):148-154.
117. Viveros MP, Arranz L, Hernanz A, Miquel J, De la Fuente M. A model of premature aging in mice based on altered stress-related behavioral response and immunosenescence. Neuroimmunomodulation. 2007;14(3-4):157-162.
118. Butcher SK, Chahal H, Nayak L, et al. Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol. Dec 2001;70(6):881-886.
119. Suzuki M, Miura S, Mori M, et al. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants. Gut. Oct 1994;35(10):1375-1378.
120. Arranz L, Fernandez C, Rodriguez A, Ribera JM, De la Fuente M. The glutathione precursor N-acetylcysteine improves immune function in postmenopausal women. Free Radic Biol Med. Nov 1 2008;45(9):1252-1262.
121. Sohal RS, Farmer KJ, Allen RG. Correlates of longevity in two strains of the housefly, Musca domestica. Mech Ageing Dev. Sep 30 1987;40(2):171-179.
122. Sohal RS, Ku HH, Agarwal S. Biochemical correlates of longevity in two closely related rodent species. Biochem Biophys Res Commun. Oct 15 1993;196(1):7-11.
123. Fulop T, Jr., Varga Z, Jacob MP, Robert L. Effect of lithium on superoxide production and intracellular free calcium mobilization in elastin peptide (kappa-elastin) and FMLP stimulated human PMNS. Effect of age. Life Sci. 1997;60(22):PL 325-332.
124. Rao KM. Age-related decline in ligand-induced actin polymerization in human leukocytes and platelets. J Gerontol. Sep 1986;41(5):561-566.
125. Piazzolla G, Tortorella C, Serrone M, Jirillo E, Antonaci S. Modulation of cytoskeleton assembly capacity and oxidative response in aged neutrophils. Immunopharmacol Immunotoxicol. May 1998;20(2):251-266.
126. Radsak MP, Salih HR, Rammensee HG, Schild H. Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol. Apr 15 2004;172(8):4956-4963.
127. Pawelec G. Immunity and ageing in man. Exp Gerontol. Dec 2006;41(12):1239-1242.
128. Puerto M, Guayerbas N, Alvarez P, De la Fuente M. Modulation of neuropeptide Y and norepinephrine on several leucocyte functions in adult, old and very old mice. J Neuroimmunol. Aug 2005;165(1-2):33-40.
129. Kalpakcioglu B, Senel K. The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Clin Rheumatol. Feb 2008;27(2):141-145.
130. Gambhir JK, Lali P, Jain AK. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem. Jun 1997;30(4):351-355.
131. Droge W, Pottmeyer-Gerber C, Schmidt H, Nick S. Glutathione augments the activation of cytotoxic T lymphocytes in vivo. Immunobiology. Aug 1986;172(1-2):151-156.
132. Staal FJ, Roederer M, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A. Dec 1990;87(24):9943-9947.
133. Mihm S, Galter D, Droge W. Modulation of transcription factor NF kappa B activity by intracellular glutathione levels and by variations of the extracellular cysteine supply. FASEB J. Feb 1995;9(2):246-252.
134. Tewes F, Bol GF, Brigelius-Flohe R. Thiol modulation inhibits the interleukin (IL)-1-mediated activation of an IL-1 receptor-associated protein kinase and NF-kappa B. Eur J Immunol. Nov 1997;27(11):3015-3021.
135. Collard CD, Vakeva A, Bukusoglu C, et al. Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation. Jul 1 1997;96(1):326-333.
136. Collard CD, Agah A, Stahl GL. Complement activation following reoxygenation of hypoxic human endothelial cells: role of intracellular reactive oxygen species, NFkappaB and new protein synthesis. Immunopharmacology. Mar 1998;39(1):39-50.
137. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta. Jul 1 2003;333(1):19-39.
138. Burek CL, Rose NR. Autoimmune thyroiditis and ROS. Autoimmun Rev. Jul 2008;7(7):530-537.
139. Lang CA, Mills BJ, Lang HL, et al. High blood glutathione levels accompany excellent physical and mental health in women ages 60 to 103 years. J Lab Clin Med. Dec 2002;140(6):413-417.
140. Bhushan M, Cumberbatch M, Dearman RJ, Andrew SM, Kimber I, Griffiths CE. Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br J Dermatol. Jan 2002;146(1):32-40.
141. Droge W, Kinscherf R. Aberrant insulin receptor signaling and amino acid homeostasis as a major cause of oxidative stress in aging. Antioxid Redox Signal. Apr 2008;10(4):661-678.
142. Kulinsky VI. Biochemical aspects of inflammation. Biochemistry (Mosc). Jun 2007;72(6):595-607.
143. Csiszar A, Wang M, Lakatta EG, Ungvari Z. Inflammation and endothelial dysfunction during aging: role of NF-kappaB. J Appl Physiol. Oct 2008;105(4):1333-1341.
144. Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev. Dec 2007;65(12 Pt 2):S140-146.
145. Yuan H, Zheng JC, Liu P, Zhang SF, Xu JY, Bai LM. Pathogenesis of Parkinson's disease: oxidative stress, environmental impact factors and inflammatory processes. Neurosci Bull. Mar 2007;23(2):125-130.
146. Chung HY, Sung B, Jung KJ, Zou Y, Yu BP. The molecular inflammatory process in aging. Antioxid Redox Signal. Mar-Apr 2006;8(3-4):572-581.
147. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr Rev. Dec 2007;65(12 Pt 2):S173-176.
148. Ostan R, Bucci L, Capri M, et al. Immunosenescence and immunogenetics of human longevity. Neuroimmunomodulation. 2008;15(4-6):224-240.
149. Meydani SN, Wu D. Age-associated inflammatory changes: role of nutritional intervention. Nutr Rev. Dec 2007;65(12 Pt 2):S213-216.
150. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. Apr 10 1997;336(15):1066-1071.
151. Victor VM, De la Fuente M. Immune cells redox state from mice with endotoxininduced oxidative stress. Involvement of NF-kappaB. Free Radic Res. Jan 2003;37(1):19-27.
152. Victor VM, Rocha M, Esplugues JV, De la Fuente M. Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des. 2005;11(24):3141-3158.
153. Gwinn MR, Vallyathan V. Respiratory burst: role in signal transduction in alveolar macrophages. J Toxicol Environ Health B Crit Rev. Jan-Feb 2006;9(1):27-39.
154. Trebilcock GU, Ponnappan U. Evidence for lowered induction of nuclear factor kappa B in activated human T lymphocytes during aging. Gerontology. 1996;42(3):137-146.
155. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev. Apr 2008;7(2):83-105.
156. Salminen A, Kauppinen A, Suuronen T, Kaarniranta K. SIRT1 longevity factor suppresses NF-kappaB -driven immune responses: regulation of aging via NF-kappaB acetylation? Bioessays. Oct 2008;30(10):939-942.
157. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol. Jun 2006;80(3):219-227.
158. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett. Apr 11 2005;579(10):2035-2039.
159. Ferencik M, Stvrtinova V, Hulin I, Novak M. Inflammation--a lifelong companion. Attempt at a non-analytical holistic view. Folia Microbiol (Praha). 2007;52(2):159-173.
160. Paolisso G, Barbieri M, Bonafe M, Franceschi C. Metabolic age modelling: the lesson from centenarians. Eur J Clin Invest. Oct 2000;30(10):888-894.
161. Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today. Jan 1995;16(1):12-16.
162. Miyaji C, Watanabe H, Toma H, et al. Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians. Hum Immunol. Sep 2000;61(9):908-916.
163. Schriner SE, Linford NJ, Martin GM, et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science. Jun 24 2005;308(5730):1909-1911.
164. Balbis E, Patriarca S, Furfaro AL, et al. Oxidative stress and antioxidant defence in a healthy nonagenarian population. Redox Rep. 2007;12(1):59-62.
165. De la Fuente M, Baeza I, Guayerbas N, et al. Changes with ageing in several leukocyte functions of male and female rats. Biogerontology. 2004;5(6):389-400.
166. Vina J, Sastre J, Pallardo FV, Gambini J, Borras C. Role of mitochondrial oxidative stress to explain the different longevity between genders: protective effect of estrogens. Free Radic Res. Dec 2006;40(12):1359-1365.
167. Ali SS, Xiong C, Lucero J, Behrens MM, Dugan LL, Quick KL. Gender differences in free radical homeostasis during aging: shorter-lived female C57BL6 mice have increased oxidative stress. Aging Cell. Dec 2006;5(6):565-574.
168. Borras C, Gambini J, Vina J. Mitochondrial oxidant generation is involved in determining why females live longer than males. Front Biosci 2007;12:1008-1013.
169. Giraldo E, Hinchado MD, Garcia JJ, Ortega E. Influence of gender and oral contraceptives intake on innate and inflammatory response. Role of neuroendocrine factors. Mol Cell Biochem. Jun 2008;313(1-2):147-153.
170. Vasto S, Candore G, Balistreri CR, et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev. Jan 2007;128(1):83-91.
171. Haus E, Lakatua DJ, Swoyer J, Sackett-Lundeen L. Chronobiology in hematology and immunology. Am J Anat. Dec 1983;168(4):467-517.
172. Haus E. Chronobiology in the endocrine system. Adv Drug Deliv Rev. Aug 31 2007;59(9-10):985-1014.
173. Esquifino AI, Cano P, Jimenez-Ortega V, Fernandez-Mateos P, Cardinali DP. Neuroendocrine-immune correlates of circadian physiology: studies in experimental models of arthritis, ethanol feeding, aging, social isolation, and calorie restriction. Endocrine. Aug 2007;32(1):1-19.
174. Rodriguez AB, Marchena JM, Nogales G, Duran J, Barriga C. Correlation between the circadian rhythm of melatonin, phagocytosis, and superoxide anion levels in ring dove heterophils. J Pineal Res. Jan 1999;26(1):35-42.
175. Terron MP, Paredes SD, Barriga C, Ortega E, Rodriguez AB. Comparative study of the heterophil phagocytic function in young and old ring doves (Streptopelia risoria) and its relationship with melatonin levels. J Comp Physiol B. Jul 2004;174(5):421-427.
176. Cardinali DP, Garcia AP, Cano P, Esquifino AI. Melatonin role in experimental arthritis. Curr Drug Targets Immune Endocr Metabol Disord. Mar 2004;4(1):1-10.
177. Srinivasan V, Spence DW, Trakht I, Pandi-Perumal SR, Cardinali DP, Maestroni GJ. Immunomodulation by melatonin: its significance for seasonally occurring diseases. Neuroimmunomodulation. 2008;15(2):93-101.
178. De la Fuente M. and Diaz B. Melatonin, aging and health. New York: Nova Science Publishers, Inc.; 2007.
179. Paredes SD, Terron MP, Marchena AM, et al. Effect of exogenous melatonin on viability, ingestion capacity, and free-radical scavenging in heterophils from young and old ringdoves (Streptopelia risoria). Mol Cell Biochem. Oct 2007;304(1-2):305-314.
180. Cardinali DP, Esquifino AI, Srinivasan V, Pandi-Perumal SR. Melatonin and the immune system in aging. Neuroimmunomodulation. 2008;15(4-6):272-278.
181. Grubeck-Loebenstein B, Berger P, Saurwein-Teissl M, Zisterer K, Wick G. No immunity for the elderly. Nat Med. Aug 1998;4(8):870.
182. Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis. Aug 2000;31(2):578-585.
183. El Yousfi M, Mercier S, Breuille D, et al. The inflammatory response to vaccination is altered in the elderly. Mech Ageing Dev. Aug 2005;126(8):874-881.
184. McElhaney JE. Overcoming the challenges of immunosenescence in the prevention of acute respiratory illness in older people. Conn Med. Sep 2003;67(8):469-474.
185. Hasler P, Zouali M. Immune receptor signaling, aging, and autoimmunity. Cell Immunol. Feb 2005;233(2):102-108.
186. Licastro F, Candore G, Lio D, et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing. May 18 2005;2:8.
187. McGeer PL, McGeer EG. Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci. Dec 2004;1035:104-116.
188. McGeer EG, Klegeris A, McGeer PL. Inflammation, the complement system and the diseases of aging. Neurobiol Aging. Dec 2005;26 Suppl 1:94-97.
189. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. Jun 2000;908:244-254.
190. Wick G, Jansen-Durr P, Berger P, Blasko I, Grubeck-Loebenstein B. Diseases of aging. Vaccine. Feb 25 2000;18(16):1567-1583.
191. Ben-Yehuda A, Weksler ME. Immune senescence: mechanisms and clinical implications. Cancer Invest. 1992;10(6):525-531.
192. Sarkar D, Fisher PB. Molecular mechanisms of aging-associated inflammation. Cancer Lett. May 8 2006;236(1):13-23.
193. Paulus WJ. Cytokines and heart failure. Heart Fail Monit. 2000;1(2):50-56.
194. Mangge H, Hubmann H, Pilz S, Schauenstein K, Renner W, Marz W. Beyond cholesterol--inflammatory cytokines, the key mediators in atherosclerosis. Clin Chem Lab Med. May 2004;42(5):467-474.
195. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. Nov 2004;15(11):2792-2800.
196. Aukrust P, Gullestad L, Ueland T, Damas JK, Yndestad A. Inflammatory and antiinflammatory cytokines in chronic heart failure: potential therapeutic implications. Ann Med. 2005;37(2):74-85.
197. van Baarle D, Tsegaye A, Miedema F, Akbar A. Significance of senescence for virusspecific memory T cell responses: rapid ageing during chronic stimulation of the immune system. Immunol Lett. Feb 15 2005;97(1):19-29.
198. Koch S, Solana R, Dela Rosa O, Pawelec G. Human cytomegalovirus infection and T cell immunosenescence: a mini review. Mech Ageing Dev. Jun 2006;127(6):538-543.
199. Franceschi C, Capri M, Monti D, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. Jan 2007;128(1):92-105.
200. Van Bodegom D, May L, Meij HJ, Westendorp RG. Regulation of human life histories: the role of the inflammatory host response. Ann N Y Acad Sci. Apr 2007;1100:84-97.
201. Vasto S, Carruba G, Lio D, et al. Inflammation, ageing and cancer. Mech Ageing Dev. Jan-Feb 2009;130(1-2):40-45.
202. Ottaviani E, Malagoli D, Capri M, Franceschi C. Ecoimmunology: is there any room for the neuroendocrine system? Bioessays. Sep 2008;30(9):868-874.
203. Finch CE, Crimmins EM. Inflammatory exposure and historical changes in human lifespans. Science. Sep 17 2004;305(5691):1736-1739.
204. Crimmins EM, Finch CE. Infection, inflammation, height, and longevity. Proc Natl Acad Sci U S A. Jan 10 2006;103(2):498-503.
205. Miquel J. Can antioxidant diet supplementation protect against age-related mitochondrial damage? Ann N Y Acad Sci. Apr 2002;959:508-516.
206. Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys. May 1 2001;389(1):84-93.
207. Guayerbas N, Puerto M, Hernanz A, Miquel J, De la Fuente M. Thiolic antioxidant supplementation of the diet reverses age-related behavioural dysfunction in prematurely ageing mice. Pharmacol Biochem Behav. Jan 2005;80(1):45-51.
208. De la Fuente M, Ferrandez MD, Burgos MS, Soler A, Prieto A, Miquel J. Immune function in aged women is improved by ingestion of vitamins C and E. Can J Physiol Pharmacol. Apr 1998;76(4):373-380.
209. Puerto M, Guayerbas N, Victor V, De la Fuente M. Effects of N-acetylcysteine on macrophage and lymphocyte functions in a mouse model of premature ageing. Pharmacol Biochem Behav. Nov 2002;73(4):797-804.
210. de la Fuente M, Ferrandez D, Munoz F, de Juan E, Miquel J. Stimulation by the antioxidant thioproline of the lymphocyte functions of old mice. Mech Ageing Dev. May 1993;68(1-3):27-36.
211. De la Fuente M, Ferrandez MD, Del Rio M, Sol Burgos M, Miquel J. Enhancement of leukocyte functions in aged mice supplemented with the antioxidant thioproline. Mech Ageing Dev. Sep 1 1998;104(3):213-225.
212. Correa R, Blanco B, Del Rio M, et al. Effect of a diet supplemented with thioproline on murine macrophage function in a model of premature ageing. Biofactors. 1999;10(2-3):195-200.
213. De La Fuente M, Miquel J, Catalan MP, Victor VM, Guayerbas N. The amount of thiolic antioxidant ingestion needed to improve several immune functions is higher in aged than in adult mice. Free Radic Res. Feb 2002;36(2):119-126.
214. Guayerbas N, Puerto M, Ferrandez MD, De La Fuente M. A diet supplemented with thiolic anti-oxidants improves leucocyte function in two strains of prematurely ageing mice. Clin Exp Pharmacol Physiol. Nov 2002;29(11):1009-1014.
215. Guayerbas N, Puerto M, Alvarez P, de la Fuente M. Improvement of the macrophage functions in prematurely ageing mice by a diet supplemented with thiolic antioxidants. Cell Mol Biol (Noisy-le-grand). 2004;50 Online Pub:OL677-681.
216. Alvarado C, Alvarez P, Jimenez L, De la Fuente M. Improvement of leukocyte functions in young prematurely aging mice after a 5-week ingestion of a diet supplemented with biscuits enriched in antioxidants. Antioxid Redox Signal. Sep-Oct 2005;7(9-10):1203-1210.
217. Alvarez P, Alvarado C, Puerto M, Schlumberger A, Jimenez L, De la Fuente M. Improvement of leukocyte functions in prematurely aging mice after five weeks of diet supplementation with polyphenol-rich cereals. Nutrition. Sep 2006;22(9):913-921.
218. Alvarado C, Alvarez P, Puerto M, Gausseres N, Jimenez L, De la Fuente M. Dietary supplementation with antioxidants improves functions and decreases oxidative stress of leukocytes from prematurely aging mice. Nutrition. Jul-Aug 2006;22(7-8):767-777.
219. Baeza I, de Castro NM, Alvarado C, et al. Improvement of immune cell functions in aged mice treated for five weeks with soybean isoflavones. Ann N Y Acad Sci. Apr 2007;1100:497-504.
220. Hernanz A, Collazos ME, de la Fuente M. Effect of age, culture medium and lymphocyte presence on ascorbate content of peritoneal macrophages from mice and guinea pigs during phagocytosis. Int Arch Allergy Appl Immunol. 1990;91(2):166-170.
221. Blanco B, Ferrandez MD, Correa R, et al. Changes in several functions of murine peritoneal macrophages by N-acetylcysteine and thioproline ingestion. Comparative effect between two strains of mice. Biofactors. 1999;10(2-3):179-185.
222. De la Fuente M, Carazo M, Correa R, Del Rio M. Changes in macrophage and lymphocyte functions in guinea-pigs after different amounts of vitamin E ingestion. Br J Nutr. Jul 2000;84(1):25-29.
223. Alvarez P, Alvarado C, Mathieu F, Jimenez L, De la Fuente M. Diet supplementation for 5 weeks with polyphenol-rich cereals improves several functions and the redox state of mouse leucocytes. Eur J Nutr. Dec 2006;45(8):428-438.
224. De la Fuente M, Victor VM. Anti-oxidants as modulators of immune function. Immunol Cell Biol. Feb 2000;78(1):49-54.
225. Sastre J, Pallardo FV, Garcia de la Asuncion J, Vina J. Mitochondria, oxidative stress and aging. Free Radic Res. Mar 2000;32(3):189-198.
226. Polidori MC, Mecocci P, Cherubini A, Senin U. Physical activity and oxidative stress during aging. Int J Sports Med. Apr 2000;21(3):154-157.
227. Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev. Jul 2000;80(3):1055-1081.
228. Ortega E, Collazos ME, Barriga C, De la Fuente M. Stimulation of the phagocytic function in guinea pig peritoneal macrophages by physical activity stress. Eur J Appl Physiol Occup Physiol. 1992;64(4):323-327.
229. Giraldo E, Garcia JJ, Hinchado MD, Ortega E. Exercise intensity-dependent changes in the inflammatory response in sedentary women: role of neuroendocrine parameters in the neutrophil phagocytic process and the pro-/anti-inflammatory cytokine balance. Neuroimmunomodulation. 2009;16(4):237-244.
230. Ortega E. Neuroendocrine mediators in the modulation of phagocytosis by exercise: physiological implications. Exerc Immunol Rev 2003;9:70-93.
231. Ortega E, Giraldo E, Hinchado MD, Martin L, Garcia JJ, De la Fuente M. Neuroimmunomodulation during exercise: role of catecholamines as 'stress mediator' and/or 'danger signal' for the innate immune response. Neuroimmunomodulation. 2007;14(3-4):206-212.
232. Powers SK, Ji LL, Leeuwenburgh C. Exercise training-induced alterations in skeletal muscle antioxidant capacity: a brief review. Med Sci Sports Exerc. Jul 1999;31(7):987-997.
233. Niess AM, Dickhuth HH, Northoff H, Fehrenbach E. Free radicals and oxidative stress in exercise--immunological aspects. Exerc Immunol Rev 1999;5:22-56.
234. Johnson P. Antioxidant enzyme expression in health and disease: effects of exercise and hypertension. Comp Biochem Physiol C Toxicol Pharmacol. Dec 2002;133(4):493-505.
235. De la Fuente M, Hernanz A, Collazos ME, Barriga C, Ortega E. Effects of physical exercise and aging on ascorbic acid and superoxide anion levels in peritoneal macrophages from mice and guinea pigs. J Comp Physiol B. 1995;165(4):315-319.
236. Smith JA, Pyne DB. Exercise, training, and neutrophil function. Exerc Immunol Rev 1997;3:96-116.
237. Colbert LH, Visser M, Simonsick EM, et al. Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc. Jul 2004;52(7):1098-1104.
238. Arranz L, De Castro, N.M., Zambrana, C., Baeza, I., Viveros, M.P., De la Fuente, M. Improvement of leukocyte functions and redox state in ageing mice by an enriched environment. Neuroimmunomodulation. 2006;13:224.